1. Home
  2. NTRA vs SW Comparison

NTRA vs SW Comparison

Compare NTRA & SW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo Smurfit WestRock plc Ordinary Shares

SW

Smurfit WestRock plc Ordinary Shares

HOLD

Current Price

$36.22

Market Cap

18.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
SW
Founded
2003
1934
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
18.7B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
SW
Price
$244.06
$36.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
10
Target Price
$227.69
$54.40
AVG Volume (30 Days)
1.7M
5.4M
Earning Date
11-06-2025
10-29-2025
Dividend Yield
N/A
4.78%
EPS Growth
N/A
109.82
EPS
N/A
1.42
Revenue
$2,116,676,000.00
$31,138,000,000.00
Revenue This Year
$32.77
$52.99
Revenue Next Year
$16.51
$2.76
P/E Ratio
N/A
$25.37
Revenue Growth
38.17
89.50
52 Week Low
$125.38
$32.73
52 Week High
$245.59
$56.05

Technical Indicators

Market Signals
Indicator
NTRA
SW
Relative Strength Index (RSI) 80.03 48.99
Support Level $233.67 $34.21
Resistance Level $240.18 $37.08
Average True Range (ATR) 7.39 0.96
MACD 0.68 0.49
Stochastic Oscillator 97.49 77.02

Price Performance

Historical Comparison
NTRA
SW

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About SW Smurfit WestRock plc Ordinary Shares

Smurfit WestRock manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. After the merger of Smurfit Kappa and WestRock in summer 2024, Smurfit WestRock became the largest producer of containerboard in the world, with substantial operations in North America, South America, and Europe.

Share on Social Networks: